Eikon Therapeutics (EIKN) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 14, 2026

Net buying: insiders sold $0 and bought $1M on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: +$1M net
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Mar 31, 2026: 2 added, 0 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about EIKN filings

Are insiders buying or selling Eikon Therapeutics, Inc. Common Stock (EIKN) stock?

Net buying: insiders sold $0 and bought $1M of EIKN stock on the open market in the 90 days to Nov 14, 2026, according to SEC Form 4 filings. The largest was Column Group IV Gp, LP (10% owner), who bought $1M. The latest filing was on Sep 8, 2026.

Which members of Congress have traded EIKN recently?

None. No member of Congress disclosed a EIKN trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this EIKN smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

CGColumn Group IV GpInsider, filed Sep 8Bought$1M

Smart money on EIKN

Lean long1 source:
- Insiders

Top traders
Couldn't load this source
Insiders
- LP Column Group IV Gp, bought $1M, open market, filed Sep 8
Lean long · thin1 buy · $1M
Form 4 filings, open market.
Congress
No recent politician filings found
Funds
No recent fund filings found
Influencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about EIKN filings

Are insiders buying or selling Eikon Therapeutics, Inc. Common Stock (EIKN) stock?

Which members of Congress have traded EIKN recently?

None. No member of Congress disclosed a EIKN trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this EIKN smart-money data?

Insiders

What insiders are doing

1 trade · 6 mo

Bought$1.0M

Buys (1)

CG
Column Group Iv Gp, Lp
10% · Sep 8
$1.0M
bought
Signals like this: n=555, 52% finished lower at D15, median -0.8% vs SPY +0.3%

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 12, 2026

Earnings landed in line with what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 12, 2026

Period ending

Sep 30, 2026

Earnings per share

-$1.59+0.88% in line

-$1.60 expected

Revenue

$0.00

Yahoo Finance

EPS and revenue: Yahoo Finance

Next report

What the street expects next

Estimates as of Nov 13, 2026

EPS expected

-$1.61

-$1.83 to -$1.38

Last 30 days

2up1down

Analysts raising estimates

Estimate drift

0.05

Change in 30 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 12, 2026	-$1.59est. -$1.60	+0.88%in line	$0.00Yahoo Finance	No year-ago quarter
Jun 30, 2026Reported Aug 13, 2026	-$1.63est. -$1.46	-11.54%miss	$0.00Yahoo Finance	No year-ago quarter
Mar 31, 2026Reported May 11, 2026	-$2.46est. -$1.22	-101.70%miss	$0.00Yahoo Finance	No year-ago quarter
Dec 31, 2025Reported Mar 30, 2026	-$26.23est. -$17.75	-47.78%miss	$0.00Yahoo Finance	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $6.78
High: $6.82
Low: $5.84
Prev close: $6.67
52-wk high: $17.40
52-wk low: $5.01
Mkt cap: $361.3M
ROE: -125.0%
P/B: 0.7x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $361M

Valuation

P/B0.71

Quality

Operating margin0.0%
ROE-125.0%
ROA-36.2%

Growth

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

39balanced

20D volatility

139%annualized

52-week range

$6.04

$5.01$17.40

20D support

$5.01recent floor

20D resistance

$8.48recent ceiling

Returns

5D +3.4%20D -19.9%60D -49.7%

Price vs moving averages

SMA20 -5.7%SMA50 -20.8%

Volume pace

0.89xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Nov 12, 2026

-$1.59est. -$1.60

+0.88%

$0.00Yahoo Finance

No year-ago quarter

Jun 30, 2026Aug 13, 2026

-$1.63est. -$1.46

-11.54%

$0.00Yahoo Finance

No year-ago quarter

Mar 31, 2026May 11, 2026

-$2.46est. -$1.22

-101.70%

$0.00Yahoo Finance

No year-ago quarter

Dec 31, 2025Mar 30, 2026

-$26.23est. -$17.75

-47.78%

$0.00Yahoo Finance

No year-ago quarter

Eikon Therapeutics, Inc. Common Stock

Smart money at a glance

What do analysts expect?

Questions about EIKN filings

Smart money on EIKN

Questions about EIKN filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings landed in line with what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Eikon Therapeutics, Inc. Common Stock

Smart money at a glance

What do analysts expect?

Questions about EIKN filings

Smart money on EIKN

Questions about EIKN filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings landed in line with what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Eikon Therapeutics, Inc. Common Stock

Overview

Questions about EIKN filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Eikon Therapeutics, Inc. Common Stock

Overview

Questions about EIKN filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.